(Q45235054)

11 December 2017

title

Inhibition of TGF-β1-receptor posttranslational core fucosylation attenuates rat renal interstitial fibrosis (English)

1 reference

11 December 2017

Nan Shen

1

1 reference

11 December 2017

Hongli Lin

2

1 reference

11 December 2017

Taihua Wu

3

1 reference

11 December 2017

Dapeng Wang

4

1 reference

11 December 2017

Weidong Wang

5

1 reference

11 December 2017

Hua Xie

6

1 reference

11 December 2017

Jianing Zhang

7

1 reference

11 December 2017

Zhe Feng

8

1 reference

11 December 2017

language of work or name

English

0 references

publication date

13 March 2013

1 reference

11 December 2017

1 reference

11 December 2017

volume

84

1 reference

11 December 2017

issue

1

1 reference

11 December 2017

page(s)

64-77

1 reference

TGF-beta in kidney fibrosis: a target for gene therapy

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.82

7 January 2021

TGF-beta in renal injury and disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.82

7 January 2021

Transforming growth factor-beta and Smad signalling in kidney diseases.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.82

7 January 2021

TGF-β - an excellent servant but a bad master

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.82

7 January 2021

Pathobiology of transforming growth factor beta in cancer, fibrosis and immunologic disease, and therapeutic considerations

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.82

7 January 2021

Transforming growth factor-beta regulation of immune responses

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.82

7 January 2021

TGFbeta signalling in control of T-cell-mediated self-reactivity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.82

7 January 2021

Biology of TGF-beta in knockout and transgenic mouse models

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.82

7 January 2021

Paclitaxel ameliorates fibrosis in hepatic stellate cells via inhibition of TGF-beta/Smad activity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.82

7 January 2021

Regulation of TGF-beta signalling by protein phosphatases

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.82

7 January 2021

Endoglin differentially modulates antagonistic transforming growth factor-beta1 and BMP-7 signaling

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.82

7 January 2021

Targeted disruption of TGF-β1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.82

7 January 2021

Analysis of expression and posttranslational modification of proteins during hypoxia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.82

7 January 2021

Simultaneous analysis of proteome, phospho- and glycoproteome of rat kidney tissue with electrostatic repulsion hydrophilic interaction chromatography

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.82

7 January 2021

Core fucose and bisecting GlcNAc, the direct modifiers of the N-glycan core: their functions and target proteins.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.82

7 January 2021

Functional roles of N-glycans in cell signaling and cell adhesion in cancer

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.82

7 January 2021

The structural basis of TGF-beta, bone morphogenetic protein, and activin ligand binding

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.82

7 January 2021

Blocking core fucosylation of TGF-β1 receptors downregulates their functions and attenuates the epithelial-mesenchymal transition of renal tubular cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.82

7 January 2021

Crystal structure of mammalian alpha1,6-fucosyltransferase, FUT8

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.82

7 January 2021

Double knockdown of alpha1,6-fucosyltransferase (FUT8) and GDP-mannose 4,6-dehydratase (GMD) in antibody-producing cells: a new strategy for generating fully non-fucosylated therapeutic antibodies with enhanced ADCC

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.82

7 January 2021

Specificity, diversity, and regulation in TGF-beta superfamily signaling.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.82

7 January 2021

Diverse roles of TGF-β receptor II in renal fibrosis and inflammation in vivo and in vitro.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.82

7 January 2021

Role of E-cadherin N-glycosylation profile in a mammary tumor model

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.82

7 January 2021

The fucosylation index of alpha-fetoprotein and its usefulness in the early diagnosis of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.82

7 January 2021

Implication of aberrant glycosylation in cancer and use of lectin for cancer biomarker discovery

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.82

7 January 2021

Detection of hepatocellular carcinoma using glycomic analysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.82

7 January 2021

Protein modifications as potential biomarkers in breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.82

7 January 2021

Identification of predictive biomarkers for response to trastuzumab using plasma FUCA activity and N-glycan identified by MALDI-TOF-MS.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.82

7 January 2021

Stachybotrydial, a potent inhibitor of fucosyltransferase and sialyltransferase

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.82

7 January 2021

Glycosylation in cellular mechanisms of health and disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.82

7 January 2021

Dysregulation of TGF-beta1 receptor activation leads to abnormal lung development and emphysema-like phenotype in core fucose-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.82

7 January 2021

Phenotype changes of Fut8 knockout mouse: core fucosylation is crucial for the function of growth factor receptor(s).

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.82

7 January 2021

Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.82

7 January 2021

Fight-or-flight: murine unilateral ureteral obstruction causes extensive proximal tubular degeneration, collecting duct dilatation, and minimal fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.82

7 January 2021

Obstructive nephropathy: insights from genetically engineered animals

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.82

7 January 2021

Pioglitazone inhibits cell growth and reduces matrix production in human kidney fibroblasts.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.82

7 January 2021

Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.82

7 January 2021

Therapy with antisense TGF-beta1 oligodeoxynucleotides reduces kidney weight and matrix mRNAs in diabetic mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.82

7 January 2021

Suppression of cyclosporine a nephrotoxicity in vivo by transforming growth factor beta receptor-immunoglobulin G chimeric protein

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.82

7 January 2021

Inhibition of TGF-beta signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine-induced liver fibrosis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.82

7 January 2021

Inhibition of p38 mitogen-activated protein kinase and transforming growth factor-beta1/Smad signaling pathways modulates the development of fibrosis in adriamycin-induced nephropathy.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.82

7 January 2021

Intracellular TGF-beta receptor blockade abrogates Smad-dependent fibroblast activation in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.82

7 January 2021

Inhibition of gene markers of fibrosis with a novel inhibitor of transforming growth factor-beta type I receptor kinase in puromycin-induced nephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.82

7 January 2021

Identifiers

DOI

10.1038/KI.2013.82

1 reference

Dimensions Publication ID

11 December 2017

1010337209

0 references

1 reference